AnaCardio appoints Elin Rosendahl as CDO

PRESS RELEASEStockholm, Sweden, April 3, 2024AnaCardio AB announces today the appointment of Elin Rosendahl, MSc as Chief Development Officer (CDO). Elin has more than 20 years of experience in managing global biopharmaceutical development programs and leading global cross-functional teams in both small and large pharma companies, and joins AnaCardio from her previous role as Vice President, Clinical Development at Vicore Pharma AB. “I am pleased to welcome Elin to our growing AnaCardio team. Her extensive leadership skills and profound knowledge in clinical development will be a great